Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 8;24(6):5192.
doi: 10.3390/ijms24065192.

miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives

Francesco Sessa  1 , Monica Salerno  1 , Massimiliano Esposito  1 , Giuseppe Cocimano  1 , Cristoforo Pomara  1
Affiliations

miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives

Francesco Sessa et al. Int J Mol Sci. .

Abstract

MicroRNAs (miRNAs), small noncoding RNAs, are post-transcriptional gene regulators that can promote the degradation or decay of coding mRNAs, regulating protein synthesis. Many experimental studies have contributed to clarifying the functions of several miRNAs involved in regulatory processes at the cardiac level, playing a pivotal role in cardiovascular disease (CVD). This review aims to provide an up-to-date overview, with a focus on the past 5 years, of experimental studies on human samples to present a clear background of the latest advances to summarize the current knowledge and future perspectives. SCOPUS and Web of Science were searched using the following keywords: (miRNA or microRNA) AND (cardiovascular diseases); AND (myocardial infarction); AND (heart damage); AND (heart failure), including studies published from 1 January 2018 to 31 December 2022. After an accurate evaluation, 59 articles were included in the present systematic review. While it is clear that miRNAs are powerful gene regulators, all the underlying mechanisms remain unclear. The need for up-to-date data always justifies the enormous amount of scientific work to increasingly highlight their pathways. Given the importance of CVDs, miRNAs could be important both as diagnostic and therapeutic (theranostic) tools. In this context, the discovery of "TheranoMIRNAs" could be decisive in the near future. The definition of well-setout studies is necessary to provide further evidence in this challenging field.

Keywords: MicroRNAs (miRNAs); TheranoMIRNAs; cardiovascular diseases (CVD); heart damage; heart failure; myocardial infarction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram illustrating included and excluded studies in this systematic review.
Figure 2
Figure 2
Distribution of selected studies by country.
See this image and copyright information in PMC

References

    1. Sturzu A.C., Wu S.M. Developmental and Regenerative Biology of Multipotent Cardiovascular Progenitor Cells. Circ. Res. 2011;108:353–364. doi: 10.1161/CIRCRESAHA.110.227066. - DOI - PMC - PubMed
    1. Catalanotto C., Cogoni C., Zardo G. MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions. Int. J. Mol. Sci. 2016;17:1712. doi: 10.3390/ijms17101712. - DOI - PMC - PubMed
    1. O’Brien J., Hayder H., Zayed Y., Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol. 2018;9:402. doi: 10.3389/fendo.2018.00402. - DOI - PMC - PubMed
    1. Wang H., Cai J. The Role of MicroRNAs in Heart Failure. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:2019–2030. doi: 10.1016/j.bbadis.2016.11.034. - DOI - PubMed
    1. Gorabi A.M., Bianconi V., Pirro M., Banach M., Sahebkar A. Regulation of cardiac stem cells by microRNAs: State-of-the-art. Biomed. Pharmacother. 2019;120:109447. doi: 10.1016/j.biopha.2019.109447. - DOI - PubMed

Publication types

MeSH terms